The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Angiogenesis and chronic inflammation: cause or consequence?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · cited 1×
“signaling on ECs represents the major rate-limiting step during the process [32].”
BackgroundInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Lately, obesity has emerged as a major public health problem due to its high prevalence and association with increased risk for development of type 2 diabetes mellitus and cardiovascular disease, two highly incident disorders in western world [193].”
BackgroundAngiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 5×
“Coordination of angiogenesis is accomplished by a variety of activators and inhibitors that sequentially synchronize the complex series of events [21].”
BackgroundInfluentialInflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Tracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 2×
“These mediators, inturn, fulfill many roles, causing vasodilatation and fluid extravasation, promoting endothelium adhesion and further recruitment of inflammatory cells [13].”
BackgroundCinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519 · cited 1×
“However, inhibition of COX-2 and synthesis of eicosanoids in atherosclerotic patients resulted in increased incidence of cardiovascular disorders [222].”
BackgroundNF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272 · cited 1×
“This inflammation–angiogenic connection is further strengthened by the enhanced expression of COX-2 in several tumor types where it up-regulates angiogenic factors, as well as, pro-inflammatory cytokines [37, 187].”
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Gerber, H.-P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30336 · Cited by 1,981
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Self-citationAsahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Harrison's Principles of Internal Medicine
Freeman, D. L. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.286.8.971-a · Cited by 1,624
VEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Matrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004 · cited 1×
“It took over three decades and numerous pre-clinical studies using many anti-angiogenic approaches to clearly demonstrate the usefulness of anti-angiogenic agents [188, 189].”
BackgroundSynovial tissue inflammation in early and late osteoarthritis
Benito, M. J., Veale, D. J., FitzGerald, O., van den Berg, W. B., & Bresnihan, B. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.025270 · Cited by 1,002
Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J. (2001) · Circulation · doi:10.1161/01.cir.103.7.926 · Cited by 1,001
Gerber, H.-P., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13313 · Cited by 981
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933 · cited 4×
“In addition to its angiogenic role in blood vessel support cells detachment, Ang-2 also up-regulates several pro-inflammatory pathways leading to leukocyte recruitment and infiltration through NF-jB signaling interaction [57].”
BackgroundInfluentialTNF-α in promotion and progression of cancer
Balkwill, F. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 915
Adipose tissue mass can be regulated through the vasculature
Rupnick, M. A., Panigrahy, D., Zhang, C.-Y., Dallabrida, S. M., Lowell, B. B., Langer, R., & Folkman, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162349799 · Cited by 845
Schmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Chemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752
Osteoarthritis, angiogenesis and inflammation
Bonnet, C. S. (2005) · Rheumatology · doi:10.1093/rheumatology/keh344 · Cited by 709
Treatment of Ulcerative Colitis with a Humanized Antibody to the α 4 β 7 Integrin
Feagan, B. G., Greenberg, G. R., Wild, G., Fedorak, R. N., Paré, P., McDonald, J. W. D., Dubé, R., Cohen, A., Steinhart, A. H., Landau, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042982 · Cited by 692
Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688
Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., & Dvorak, H. F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1141 · Cited by 685
Clarke, M. C. H., Figg, N., Maguire, J. J., Davenport, A. P., Goddard, M., Littlewood, T. D., & Bennett, M. R. (2006) · Nature Medicine · doi:10.1038/nm1459 · Cited by 646
Inflammation as a Tumor Promoter in Cancer Induction
Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640
Angiopoietins: a link between angiogenesis and inflammation
Fiedler, U., & Augustin, H. G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.004 · Cited by 606
Reversal of obesity by targeted ablation of adipose tissue
Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004) · Nature Medicine · doi:10.1038/nm1048 · Cited by 601
Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith, M. F., Foley, E., Moskaluk, C. A., Bickston, S. J., & Cominelli, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6829 · Cited by 572
Ben-Av, P., Crofford, L. J., Wilder, R. L., & Hla, T. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00956-a · Cited by 566
Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.
Smith, M., Triantafillou, S., Parker, A., Youssef, P. P., & Coleman, M. (1997) · PubMed · Cited by 525
Macrophage Depletion Inhibits Experimental Choroidal Neovascularization
Sakurai, E., Anand, A., Ambati, B. K., van Rooijen, N., & Ambati, J. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0097 · Cited by 503
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
Obesity, adipocytokines, and insulin resistance in breast cancer
Rose, D. P., Komninou, D., & Stephenson, G. D. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00142.x · Cited by 460
Lowes, M. A., Chamian, F., Abello, M. V., Fuentes-Duculan, J., Lin, S.-L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509736102 · Cited by 456
Hypoxia Regulates Macrophage Functions in Inflammation
Murdoch, C., Muthana, M., & Lewis, C. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6257 · Cited by 455
Targeting cyclooxygenase-2 in human neoplasia
Dannenberg, A. J., & Subbaramaiah, K. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00310-6 · Cited by 446
Naturally Occurring NF-κB Inhibitors
Nam, N.-H. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706777934937 · Cited by 436
Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G. L., Volpert, O. V., Íñiguez, M. A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 432
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Amano, S., Ogura, Y., Hida, T., Oguchi, Y., Ambati, J., Miller, J. W., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022027 · Cited by 421
Bonen, D. K., Ogura, Y., Nicolae, D. L., Inohara, N., Saab, L., Tanabe, T., Chen, F. F., Foster, S. J., Duerr, R. H., Brant, S. R., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50019 · Cited by 418
Humoral immunity, inflammation and cancer
Tan, T.-T., & Coussens, L. M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.001 · Cited by 417
Spector, T. D., Hart, D. J., Nandra, D., Doyle, D. V., Mackillop, N., Gallimore, J. R., & Pepys, M. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400419 · Cited by 403
Inflammation and angiogenesis in osteoarthritis
Haywood, L., McWilliams, D. F., Pearson, C. I., Gill, S. E., Ganesan, A., Wilson, D., & Walsh, D. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11094 · Cited by 395
Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 395
Creamer, P., & Hochberg, M. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07226-7 · Cited by 394
Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis
Danese, S., Sans, M., de la Motte, C., Graziani, C., West, G., Phillips, M. H., Pola, R., Rutella, S., Willis, J., Gasbarrini, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.054 · Cited by 374
Xia, Y.-P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D., & Rudge, J. S. (2003) · Blood · doi:10.1182/blood-2002-12-3793 · Cited by 367
Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis
Fukumura, D., Ushiyama, A., Duda, D. G., Xu, L., Tam, J., Krishna, V., Chatterjee, K., Garkavtsev, I., & Jain, R. K. (2003) · Circulation Research · doi:10.1161/01.res.0000099243.20096.fa · Cited by 365
Angiogenesis in rheumatoid arthritis.
Paleolog, E. M. (2002) · Arthritis Research · doi:10.1186/ar575 · Cited by 363
The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis
Gately, S. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026575610124 · Cited by 359
Ina, K., Itoh, J., Fukushima, K., Kusugami, K., Yamaguchi, T., Kyokane, K., Imada, A., Binion, D. G., Musso, A., West, G. A., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.1081 · Cited by 345
Angiogenesis—a new target for future therapy
Pandya, N. M., Dhalla, N. S., & Santani, D. D. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.01.005 · Cited by 345
Cyclooxygenase-2 and prostaglandins in articular tissues
Martel-Pelletier, J., Pelletier, J.-P., & Fahmi, H. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(03)00134-3 · Cited by 333
Guidebook to the extracellular matrix, anchor, and adhesion proteins
Kreis, T. E., & Vale, R. D. (1999) · Medical Entomology and Zoology · Cited by 331
Paleolog, E. M., Young, S., Stark, A. C., McCloskey, R. V., Feldmann, M., & Maini, R. N. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1258::aid-art17>3.0.co;2-1 · Cited by 325
Signal transduction of inflammatory cytokines and tumor development
Yoshimura, A. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00197.x · Cited by 314
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
Storgard, C. M., Stupack, D. G., Jonczyk, A., Goodman, S. L., Fox, R. I., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3756 · Cited by 310
Role of Inflammatory Mediators in Angiogenesis
Naldini, A., & Carraro, F. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010053622830 · Cited by 287
Neutrophil-Derived Cytokines: Potential Therapeutic Targets in Inflammation
Kasama, T., Miwa, Y., Isozaki, T., Odai, T., Adachi, M., & Kunkel, S. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010054022114 · Cited by 286
Costa, C., Soares, R., Reis-Filho, J. S., Leitao, D., Amendoeira, I., & Schmitt, F. C. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.6.429 · Cited by 275
Self-citationTargeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration
Ng, E. W. M., & Adamis, A. P. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80078-x · Cited by 273
Methotrexate for induction of remission in refractory Crohn's disease
McDonald, J. W., Wang, Y., Tsoulis, D. J., MacDonald, J. K., & Feagan, B. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003459.pub4 · Cited by 270
Metalloproteases and inhibitors in arthritic diseases
Martel-Pelletier, J., Welsch, D. J., & Pelletier, J.-P. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0195 · Cited by 270
Platelets and Chemokines in Atherosclerosis: Partners in Crime
Weber, C. (2005) · Circulation Research · doi:10.1161/01.res.0000160077.17427.57 · Cited by 265
Hatoum, O. A., Binion, D. G., Otterson, M. F., & Gutterman, D. D. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00699-1 · Cited by 260
Esposito, I., Menicagli, M., Funel, N., Bergmann, F., Boggi, U., Mosca, F., Bevilacqua, G., & Campani, D. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014498 · Cited by 257
Kerner, A., Avizohar, O., Sella, R., Bartha, P., Zinder, O., Markiewicz, W., Levy, Y., Brook, G. J., & Aronson, D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000148324.63685.6a · Cited by 257
The Price of Sight — Ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration
Steinbrook, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068185 · Cited by 255
Wheeler-Jones, C., Abu-Ghazaleh, R., Cospedal, R., Houliston, R. A., Martin, J., & Zachary, I. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01481-6 · Cited by 255
Waltenberger, J., Lange, J., & Kranz, A. (2000) · Circulation · doi:10.1161/01.cir.102.2.185 · Cited by 252
Bora, P. S., Sohn, J.-H., Cruz, J. M. C., Jha, P., Nishihori, H., Wang, Y., Kaliappan, S., Kaplan, H. J., & Bora, N. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.491 · Cited by 249
Saijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.469 · Cited by 249
Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety
Dubinsky, M. C. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00344-1 · Cited by 249
Steed, D. L. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000222526.21512.4c · Cited by 248
New genes in inflammatory bowel disease: lessons for complex diseases?
Gaya, D. R., Russell, R. K., Nimmo, E. R., & Satsangi, J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68345-1 · Cited by 245
Walsh, D. (1999) · Rheumatology · doi:10.1093/rheumatology/38.2.103 · Cited by 234
Wilder, R. L. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii96 · Cited by 232
Jackson, J. R., Minton, J. A. L., Ho, M. L., Wei, N., & Winkler, J. (1997) · PubMed · Cited by 227
Analysis of the histologic variation of synovitis in rheumatoid arthritis
Rooney, M., Condell, D., Quinlan, W., Daly, L., Whelan, A., Feighery, C., & Bresnihan, B. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310803 · Cited by 223
Adhesion molecule expression in human synovial tissue
Johnson, B. A., Haines, G. K., Harlow, L. A., & Koch, A. E. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360203 · Cited by 211
Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy
Zhang, S. X., & Ma, J.-X. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.09.002 · Cited by 208
Angiogenesis as a target in rheumatoid arthritis
Koch, A. E. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii60 · Cited by 204
Schaub, F. J., Han, D. K. M., Conrad Liles, W., Adams, L. D., Coats, S. A., Ramachandran, R. K., Seifert, R. A., Schwartz, S. M., & Bowen-Pope, D. F. (2000) · Nature Medicine · doi:10.1038/77521 · Cited by 202
LUTTUN, A., TJWA, M., & CARMELIET, P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04870.x · Cited by 202
Kabelitz, D., & Medzhitov, R. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.11.018 · Cited by 197
Targeting leukocyte integrins in human diseases
Yonekawa, K., & Harlan, J. M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804460 · Cited by 194
Angiogenesis inhibition suppresses collagen arthritis.
Peacock, D. J., Banquerigo, M. L., & Brahn, E. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.1135 · Cited by 188
Review article: adipocytokines and insulin resistance
VETTOR, R., MILAN, G., ROSSATO, M., & FEDERSPIL, G. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02587.x · Cited by 185
Prostaglandins and bone: physiology and pathophysiology
Raisz, L. G. (1999) · Osteoarthritis and Cartilage · doi:10.1053/joca.1998.0230 · Cited by 184
Ciulla, T. A. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.3.399 · Cited by 182
Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing
Girardin, S. E., Hugot, J., & Sansonetti, P. J. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.10.007 · Cited by 181
Lingen, M. W. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0067-rolaec · Cited by 177
Synovial inflammation in patients with early osteoarthritis of the knee.
Myers, S. L., Brandt, K. D., Ehlich, J. W., Braunstein, E. M., Shelbourne, K. D., Heck, D. A., & Kalasinski, L. A. (1990) · PubMed · Cited by 175
Veillard, N. R., Braunersreuther, V., Arnaud, C., Burger, F., Pelli, G., Steffens, S., & Mach, F. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.015 · Cited by 175
Lee, S., Joo, Y.-S., Kim, W., Min, D. J., Min, J., Park, S. H., Cho, C. S., & Kim, H. (2001) · PubMed · Cited by 174
Smith, M. D., Barg, E., Weedon, H., Papengelis, V, Smeets, T., Tak, P. P., Kraan, M., Coleman, M., & Ahern, M. J. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.4.303 · Cited by 173
The role of VEGF and thrombospondins in skin angiogenesis
Detmar, M. (2000) · Journal of Dermatological Science · doi:10.1016/s0923-1811(00)00145-6 · Cited by 168
Molecular and cellular basis of rheumatoid joint destruction
Karouzakis, E., Neidhart, M., Gay, R. E., & Gay, S. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.04.011 · Cited by 167 · cited 1×
“These induce the ongoing recruitment of immune cells, resulting in the up-regulation of adhesion molecules on the synovial endothelium and allowing their migration into the joint [83–86].”
BackgroundMurakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y., & Shibuya, M. (2006) · Blood · doi:10.1182/blood-2006-04-016030 · Cited by 166
Creamer, D., Sullivan, D., Bicknell, R., & Barker, J. (2002) · Angiogenesis · doi:10.1023/a:1024515517623 · Cited by 165
Pacifico, F., & Leonardi, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.032 · Cited by 165
Evidence for the Notch Signaling Pathway on the Role of Estrogen in Angiogenesis
Soares, R. A., Balogh, G., Guo, S., Gärtner, F., Russo, J., & Schmitt, F. C. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0362 · Cited by 165
Self-citationTreatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis
Miotla, J., Maciewicz, R., Kendrew, J., Feldmann, M., & Paleolog, E. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780127 · Cited by 164
Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
Beaudeux, J.-L., Giral, P., Bruckert, E., Foglietti, M.-J., & Chapman, M. J. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.024 · Cited by 163
EXPRESSION OF CYCLOOXYGENASE-2 IN HUMAN AND AN ANIMAL MODEL OF RHEUMATOID ARTHRITIS
KANG, R. Y., FREIRE-MOAR, J., SIGAL, E., & CHU, C.-Q. (1996) · Rheumatology · doi:10.1093/rheumatology/35.8.711 · Cited by 161
The role of endothelial cell apoptosis in inflammatory and immune diseases
Winn, R. K., & Harlan, J. M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01378.x · Cited by 159
Argraves, K. M., Battey, F. D., MacCalman, C. D., McCrae, K. R., Gåfvels, M. E., Kozarsky, K., Chappell, D. A., Strauss, J. F., & Strickland, D. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26550 · Cited by 153
Hammond, T. G., Lewis, F. C., Goodwin, T. J., Linnehan, R. M., Wolf, D. A., Hire, K. P., Campbell, W. C., Benes, E. N., O’Reilly, K. C., Globus, R. K., et al. (1999) · Nature Medicine · doi:10.1038/7331 · Cited by 147
Vascular Endothelial Growth Factor Expression and Regulation of Murine Collagen-Induced Arthritis
Lu, J., Kasama, T., Kobayashi, K., Yoda, Y., Shiozawa, F., Hanyuda, M., Negishi, M., Ide, H., & Adachi, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5922 · Cited by 146
Koenders, M. I., Joosten, L. A. B., & van den Berg, W. B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058529 · Cited by 145
the Vasculature and Inflammatory Bowel Disease. Contribution to Pathogenesis and Clinical Pathology
Hatoum, O. A., & Binion, D. G. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160772.78951.61 · Cited by 143
TWEAK Is a Novel Arthritogenic Mediator
Perper, S. J., Browning, B., Burkly, L. C., Weng, S., Gao, C. O., Giza, K., Su, L., Tarilonte, L., Crowell, T., Rajman, L. A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2610 · Cited by 142
Majno, G. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65648-9 · Cited by 138
Monaco, C. G., Andreakos, E., Kiriakidis, S., Feldmann, M., & Paleolog, E. M. (2004) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010043483881 · Cited by 138
Cytokine networks—towards new therapies for rheumatoid arthritis
McInnes, I. B., & Liew, F. Y. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0020 · Cited by 138
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts
Honorati, M. C., Neri, S., Cattini, L., & Facchini, A. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.10.004 · Cited by 137
Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.
Otani, A., Takagi, H., Oh, H., Koyama, S., Matsumura, M., & Honda, Y. (1999) · PubMed · Cited by 134
Vascular Endothelial Growth Factor in Patients with Rheumatoid Arthritis
Harada, K. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/03009749850154429 · Cited by 134
Protection From Obesity in Mice Lacking the VLDL Receptor
Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E. H., Gijbels, M. J. J., van Dijk, K. W., Havekes, L. M., & Jong, M. C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095147 · Cited by 133
Regulation of Gene Expression by HIF‐1
Semenza, G. L., Shimoda, L. A., & Prabhakar, N. R. (2006) · Novartis Foundation symposium · doi:10.1002/9780470035009.ch2 · Cited by 132
Interleukin-6: a new therapeutic target
Smolen, J., & Maini, R. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1969 · Cited by 131
Cho, M.-C., Jung, Y. H., MOON, Y., Min, S., YOON, C., LEE, S., PARK, S., CHO, C., Jue, D., & KIM, H. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.10.020 · Cited by 129
Cytokines and chemokines as regulators of angiogenesis in health and disease.
Benelli, R., Lorusso, G., Albini, A., & Noonan, D. (2006) · Current pharmaceutical design · doi:10.2174/138161206777947461 · Cited by 127
The role of angiogenesis in rheumatoid arthritis: recent developments
Koch, A. E. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i65 · Cited by 122
MIKHAILENKO, I. A., Krylov, D. Y., Argraves, K. M., Roberts, D. D., Liau, G., & Strickland, D. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6784 · Cited by 120
Growth hormone, VEGF and FGF: Involvement in rheumatoid arthritis
Malemud, C. J. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.06.033 · Cited by 120
Phenotypic Characterization of Inflammatory Cells from Osteoarthritic Synovium and Synovial Fluids
Haynes, M. K., Hume, E. L., & Smith, J. B. (2002) · Clinical Immunology · doi:10.1006/clim.2002.5283 · Cited by 117
Regression of neovascular age-related macular degeneration following infliximab therapy
Markomichelakis, N. N., THEODOSSIADIS, P. G., & Sfikakis, P. P. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.09.058 · Cited by 115
Sang, Q. A., Jin, Y., Newcomer, R., Monroe, S., Fang, X., Hurst, D. R., Lee, S., Cao, Q., & Schwartz, M. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776287045 · Cited by 112
Microbes and malignancy : infection as a cause of human cancers
Parsonnet, J. (1999) · Cited by 109
Angiogenesis and ophthalmic disease
Adamis, A. P., Aiello, L. P., & D’Amato, R. A. (1999) · Angiogenesis · doi:10.1023/a:1009071601454 · Cited by 109
Sone, H., Kawakami, Y., Sakauchi, M., Nakamura, Y., Takahashi, A., Shimano, H., Okuda, Y., Segawa, T., Suzuki, H., & Yamada, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4395 · Cited by 107
Miller, W. H., Keenan, R. M., Willette, R. N., & Lark, M. W. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01545-2 · Cited by 102
Giatromanolaki, A. N., Sivridis, E., Athanassou, N., Zois, E., Thorpe, P. E., Brekken, R. A., Gatter, K. C., Harris, A. L., Koukourakis, I. M., & Koukourakis, M. I. (2001) · The Journal of Pathology · doi:10.1002/path.842 · Cited by 101
Park, Y. W., Kang, Y. M., Butterfield, J., Detmar, M. J., Goronzy, J. J., & Weyand, C. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63259-2 · Cited by 97
Kasza, A., Petersen, H. H., Heegaard, C. W., Oka, K., Christensen, A., Dubin, A., Chan, L., & Andreasen, P. A. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00270.x · Cited by 96
Gong, R., Rifai, A., & Dworkin, L. D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020185 · Cited by 95
Ryu, S., Lee, J. H., & Kim, S. I. (2005) · Clinical Rheumatology · doi:10.1007/s10067-005-1081-1 · Cited by 92
Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy
Mitamura, Y., Takeuchi, S., Matsuda, A., Tagawa, Y., Mizue, Y., & Nishihira, J. (2001) · Ophthalmologica · doi:10.1159/000050900 · Cited by 90
Duraisamy, Y., SLEVIN, M. A., Smith, N., Bailey, J., Zweit, J., Smith, C. A., Ahmed, N., & Gaffney, J. J. (2001) · Angiogenesis · doi:10.1023/a:1016068917266 · Cited by 87
Chang, J. H., McCluskey, P., & Wakefield, D. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1113 · Cited by 87
Angiogenesis, Arteriogenesis, and Diabetes
Simons, M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.008 · Cited by 86
Scott, B. B., Zaratin, P., Colombo, A., Hansbury, M., Winkler, J. D., & Jackson, J. R. (2002) · PubMed · Cited by 85
Nickoloff, B. J., Bonish, B. K., Marble, D. J., Schriedel, K. A., DiPietro, L. A., Gordon, K. B., & Lingen, M. W. (2006) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsymp.5650010 · Cited by 83
The role of chemokines in rheumatoid arthritis and osteoarthritis
Vergunst, C. E., van de Sande, M. G. H., Lebre, M. C., & Tak, P. P. (2005) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740500439159 · Cited by 82
Pro-Inflammatory Cytokines in Rheumatoid Arthritis: Pathogenetic and Therapeutic Aspects
Smolen, J. S., Redlich, K., Zwerina, J., Aletaha, D., Steiner, G. E., & Schett, G. A. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:3:239 · Cited by 81
Mechanisms of tissue damage in inflammatory bowel disease
Pallone, F., & Monteleone, G. (2001) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200107000-00002 · Cited by 81
Costa, C., Soares, R. A., & Schmitt, F. C. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm11207-0802.x · Cited by 79
Self-citationCellular and Molecular Mechanisms of the Epithelial Repair in IBD
Okamoto, R., & Watanabe, M. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2804-5 · Cited by 79
Adipocyte Size and Liability to Cell Death
Monteiro, R., de Castro, P. M. S. T., Calhau, C., & Azevedo, I. (2006) · Obesity Surgery · doi:10.1381/096089206777346600 · Cited by 79
Inflammation as an important feature of osteoarthritis.
Brooks, P. (2003) · PubMed · Cited by 78
Nielsen, H. J., Christensen, I. J., Svendsen, M. N., Hansen, U., Werther, K., Brünner, N., Petersen, L. J., & Jk, K. (2002) · Inflammation Research · doi:10.1007/pl00012428 · Cited by 77
Bandt, M. D., Grossin, M., Weber, A., Chopin, M., Elbim, C., Pla, M., Gougerot‐Pocidalo, M., & Gaudry, M. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<2056::aid-anr17>3.0.co;2-2 · Cited by 75
The role of COX-2 in angiogenesis and rheumatoid arthritis☆
Woods, J. M., Mogollon, A., Amin, M. A., Martinez, R. J., & Koch, A. E. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00019-4 · Cited by 75
Oral treatment options for degenerative joint disease—presence and future
Steinmeyer, J., & Konttinen, Y. T. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.007 · Cited by 74
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Inflammatory Triggers of Lymphangiogenesis
Mouta, C., & Héroult, M. (2003) · Lymphatic Research and Biology · doi:10.1089/153968503768330247 · Cited by 69
Vascular endothelial growth factor in inflammatory bowel disease
Kapsoritakis, A. N., Sfiridaki, A., Maltezos, E. S., Simopoulos, K., Giatromanolaki, A. N., Sivridis, E., & Koukourakis, M. I. (2003) · International Journal of Colorectal Disease · doi:10.1007/s00384-003-0495-y · Cited by 65
New approaches in the pharmacological treatment of obesity
Leonhardt, M., Hrupka, B. J., & Langhans, W. (1999) · European Journal of Nutrition · doi:10.1007/s003940050040 · Cited by 65
Conrozier, T., Chapuis‐Cellier, C., Richard, M., Mathieu, P., Richard, S., & Vignon, E. P. (1998) · PubMed · Cited by 64
Ohnishi, T., & Daikuhara, Y. (2003) · Archives of Oral Biology · doi:10.1016/s0003-9969(03)00180-8 · Cited by 63
Mast cells in rheumatoid arthritis
Maruotti, N., Enrico Crivellato, B., Cantatore, F. P., Vacca, A., & Ribatti, D. (2006) · Clinical Rheumatology · doi:10.1007/s10067-006-0305-3 · Cited by 62
Safety of anti-inflammatory treatment--new ways of thinking
Brune, K. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh104 · Cited by 61
Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies
Paleolog, E. M., & Fava, R. A. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00832000 · Cited by 60
Chemokine networks in inflammatory skin diseases.
Pastore, S., Mascia, F., Mariotti, F., Dattilo, C., & Girolomoni, G. (2004) · PubMed · Cited by 59
Hembrough, T., Ruiz, J. F., Swerdlow, B., Swartz, G. M., Hammers, H. J., Zhang, L., Plum, S. M., Williams, M. S., Strickland, D. K., & Pribluda, V. S. (2004) · Blood · doi:10.1182/blood-2003-07-2234 · Cited by 57
Cordiali‐Fei, P., Trento, E., D’Agosto, G., Bordignon, V., Mussi, A., Ardigò, M., Mastroianni, A., Vento, A., Solivetti, F. M., Berardesca, E., et al. (2006) · Journal of Autoimmune Diseases · doi:10.1186/1740-2557-3-5 · Cited by 56
VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis.
Etherington, P. J., Winlove, P., Taylor, P. C., Paleolog, E. M., & Miotla, J. M. (2002) · PubMed · Cited by 56
Cited by
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
The role of macrophage phenotype in vascularization of tissue engineering scaffolds
Spiller, K. L., Anfang, R. R., Spiller, K. J., Ng, J., Nakazawa, K. R., Daulton, J. W., & Vunjak-Novakovic, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.012 · Cited by 948
Valavanidis, A., Vlachogianni, T., Fiotakis, K., & Loridas, S. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10093886 · Cited by 910
Metadata
- Authors
- Costa, C., Incio, J., & Soares, R.
- Venue
- Angiogenesis
- Published
- 2007-04-25
- Volume
- 10
- Issue
- 3
- Pages
- 149-166
- ISSN
- 0969-6970 (ISSN-L)
- 1573-7209
- OpenAlex
- W1998409162
- Cited by
- 504
- References
- 216
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.